COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 202 filers reported holding COHERUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,262 | +84.5% | 3,815 | +110.8% | 0.00% | – |
| Q2 2023 | $7,728 | -37.6% | 1,810 | 0.0% | 0.00% | – |
| Q1 2023 | $12,380 | -14.5% | 1,810 | 0.0% | 0.00% | – |
| Q4 2022 | $14,482 | +1348.2% | 1,810 | +2054.8% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 84 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -87.5% | 84 | -85.3% | 0.00% | – |
| Q1 2022 | $8,000 | -66.7% | 571 | -62.8% | 0.00% | – |
| Q4 2021 | $24,000 | +41.2% | 1,537 | +37.5% | 0.00% | – |
| Q3 2021 | $17,000 | +70.0% | 1,118 | +50.1% | 0.00% | – |
| Q2 2021 | $10,000 | +66.7% | 745 | +69.7% | 0.00% | – |
| Q1 2021 | $6,000 | +50.0% | 439 | +116.3% | 0.00% | – |
| Q4 2020 | $4,000 | -78.9% | 203 | -80.6% | 0.00% | – |
| Q3 2020 | $19,000 | +90.0% | 1,045 | +91.7% | 0.00% | – |
| Q2 2020 | $10,000 | -87.8% | 545 | -89.4% | 0.00% | – |
| Q1 2020 | $82,000 | – | 5,165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |